Thromoboagiitis obliterans (TAO)

International Journal of Stem Cells

Volumn 3, Issue 1, 2010, Pages 1-7

  Park, Ui Jun ^a   Kim, Dong Ik ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Angiogenesis; Stem cells; Thromboangiitis obliterans

Indexed keywords

NICOTIANA TABACUM;

EID: 80051583724     PISSN: 20053606     EISSN: 20055447     Source Type: Journal    
DOI: 10.15283/ijsc.2010.3.1.1     Document Type: Article

References (62)

1. Olin JW. Thromboangiitis Obliterans (Buerger's Disease). N Engl J Med 2000;343:864-869
2. Buerger L. Thrombo-angiitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangrene. Am J Med Sci 1908:567-580
3. Lie JT. The rise and fall and resurgence of thromboangiitis obliterans (Buerger's disease). Acta Pathol Jpn h1989;39:153-158
4. Kobayashi M, Ito M, Nakagawa A, Nishikimi N, Nimura Y. Immunohistochemical analysis of arterial wall cellular infiltration in Buerger's disease (endarteritis obliterans). J Vasc Surg 1999;29:451-458
5. Malecki R, Zdrojowy K, Adamiec R. Thromboangiitis obliterans in the 21st century- A new face of disease. Atherosclerosis 2009;206:328-334
6. Matsushita M, Nishikimi N, Sakurai T, Nimura Y. Decrease in prevalence of Buerger's disease in Japan. Surgery 1998;124:498-502
7. Grove WJ, Stansby GP. Buerger's disease and cigarette smoking in Bangladesh. Ann R Coll Surg Engl 1992;74: 115-117
8. Papa M, Bass A, Adar R, Halperin Z, Schneiderman J, Becker CG, Brautbar H, Mozes E. Autoimmune mechanisms in thromboangiitis obliterans (Buerger's disease): the role of tobacco antigen and the major histocompatibility complex. Surgery 1992;111:527-531
9. McLoughlin GA, Helsby CR, Evans CC, Chapman DM. Association of HLA-A9 and HLA-B5 with Buerger's disease. Br Med J 1976;2:1165-1166
10. Chen Z, Takahashi M, Naruse T, Nakajima T, Chen YW, Inoue Y, Ishikawa I, Iwai T, Kimura A. Synergistic contribution of CD14 and HLA loci in the susceptibility to Buerger disease. Hum Genet 2007;122:367-372
11. Yörükoglu Y, Ilgit E, Zengin M, Nazliel K, Salman E, Yucel E. Thromboangiitis obliterans (buerger's disease) in women (a reevaluation). Angiology 1993;44:527-532
12. Papa MZ, Adar R. A critical look at thromboangiitis obliterans (Buerger's disease). Vasc Surg 1992;5:1-18
13. Shionoya S. What is Buerger's disease? World J of Surg 1983;7:544-551
14. Lie JT. Thromboangiitis obliterans (Buerger's disease) in an elderly man after cessation of cigarette smoking--a case report. Angiology 1987;38:864-867
15. Lie JT. Thromboangiitis obliterans (Buerger's disease) and smokeless tobacco. Arthritis Rheum 1988;31:812-813
16. Rahman M, Chowdhury AS, Fukui T, Hira K, Shimbo T. Association of thromboangiitis obliterans with cigarette and bidi smoking in Bangladesh: a case-control study. Int. J. Epidemiol 2000;29:266-270
17. Sasaki S, Sakuma M, Kunihara T, Yasuda K. Current trends in thromboangiitis obliterans (Buerger's disease) in women. Am J Surg 1999;177:316-320
18. Mills JL Sr. Buerger's disease in the 21st century: diagnosis, clinical features, and therapy. Semin Vasc Surg 2003;16: 179-189
19. Shionoya S. Diagnostic criteria of Buerger's disease. Int J Cardiol 1998;66(Suppl 1):S243-245
20. Eichhorn J, Sima D, Lindschau C, Turowski A, Schmidt H, Schneider W, Haller H, Luft FC. Antiendothelial cell antibodies in thromboangiitis obliterans. Am J Med Sci 1998; 315:17-23
21. Halacheva K, Gulubova MV, Manolova I, Petkov D. Expression of ICAM-1, VCAM-1, E-selectin and TNF-alpha on the endothelium of femoral and iliac arteries in thromboangiitis obliterans. Acta Histochem 2002;104:177-184
22. Adar R, Papa MZ, Halpern Z, Mozes M, Shoshan S, Sofer B, Zinger H, Dayan M, Mozes E. Cellular sensitivity to collagen in thromboangiitis obliterans. N Engl J Med 1983; 308:1113-1116
23. Makita S, Nakamura M, Murakami H, Komoda K, Kawazoe K, Hiramori K. Impaired endothelium-dependent vasorelaxation in peripheral vasculature of patients with thromboangiitis obliterans (Buerger's disease). Circulation 1996; 94:II211-215
24. Mills JL, Porter JM. Buerger's disease (thromboangiitis obliterans). Ann Vasc Surg 1991;5:570-572
25. Olin JW, Young JR, Graor RA, Ruschhaupt WF, Bartholomew JR. The changing clinical spectrum of thromboangiitis obliterans (Buerger's disease). Circulation 1990;82(5 Suppl): IV3-8
26. Becit N, Unlu Y, Kocak H, Ceviz M. Involvement of the coronary artery in a patient with thromboangiitis obliterans. A case report. Heart Vessels 2002;16:201-203
27. Cordobes Gual J, Riera Vázquez R, Merino Mairal O, Manuel-Rimbau Muñoz E, Lozano Vilardell P, Company Campins M. Buerger's disease with intestinal ischemic involvement. An Med Interna 2005;22:235-237
28. No YJ, Lee EM, Lee DH, Kim JS. Cerebral angiographic findings in thromboangiitis obliterans. Neuroradiology 2005; 47:912-915
29. Siddiqui MZ, Reis ED, Soundararajan K, Kerstein MD. Buerger's disease affecting mesenteric arteries: a rare cause of intestinal ischemia-a case report. Vasc Surg 2001;35:235-238
30. Wysokinski WE, Kwiatkowska W, Maslowski L, Witkiewicz W, Kowal-Gierczak B. Buerger's disease in two brothers: iliac artery occlusion by thromboangiitis obliterans-case reports. Angiology 1998;49:409-414
31. Mills JL, Porter JM. Buerger's disease: a review and update. Semin Vasc Surg 1993;6:14-23
32. Papa MZ, Rabi I, Adar R. A point scoring system for the clinical diagnosis of Buerger's disease. Eur J Vasc Endovasc Surg 1996;11:335-339
33. Suzuki S, Mine H, Umehara I, Yoshida T, Okada Y. Buerger's disease (thromboangiitis obliterans): an analysis of the arteriograms of 119 cases. Clin Radiol 1982;33:235-240
34. Cooper LT, Tse TS, Mikhail MA, McBane RD, Stanson AW, Ballman KV. Long-term survival and amputation risk in thromboangiitis obliterans (Buerger's disease). J Am Coll Cardiol 2004;44:2410-2411
35. Börner C, Heidrich H. Long-term follow-up of thromboangiitis obliterans. Vasa 1998;27:80-86
36. Bozkurt AK, Köksal C, Demirbas MY, Erdoǧan A, Rahman A, Demirkilic U, Ustunsoy H, Metin G, Yillik L, Onol H, Cinar B, Karaçelik M, Erdinc I, Bolcal C, Sayin AG. Turkish Buerger's Disease Research Group. A randomized trial of intravenous iloprost (a stable prostacyclin analogue) versus lumbar sympathectomy in the management of Buerger's disease. Int Angiol 2006;25:162-168
37. Oral iloprost in the treatment of thromboangiitis obliterans (Buerger's disease): a double-blind, randomised, placebo-controlled trial. The European TAO Study Group. Eur J Vasc Endovasc Surg 1998;15:300-307
38. Lau H, Cheng SW. Buerger's disease in Hong Kong: a review of 89 cases. Aust N Z J Surg 1997;67:264-269
39. Swigris JJ, Olin JW, Mekhail NA. Implantable spinal cord stimulator to treat the ischemic manifestations of thromboangiitis obliterans (Buerger's disease). J Vasc Surg 1999;29:928-935
40. Donas KP, Schulte S, Ktenidis K, Horsch S. The role of epidural spinal cord stimulation in the treatment of Buerger's disease. J Vasc Surg 2005;41:830-836
41. Sayin A, Bozkurt AK, Tuzun H, Vural FS, Erdog G, Ozer M. Surgical treatment of Buerger's disease: experience with 216 patients. Cardiovasc Surg 1993;1:377-380
42. Sasajima T, Kubo Y, Inaba M, Goh K, Azuma N. Role of infrainguinal bypass in Buerger's disease: an eighteen-year experience. Eur J Vasc Endovasc Surg 1997;13:186-192
43. Lehoux S, Lévy BI. Collateral artery growth: making the most of what you have. Circ Res 2006;99:567-569
44. Sugihara S, Yamamoto Y, Matsubara K, Ishida K, Matsuura T, Ando F, Igawa G, Narazaki G, Miake J, Tajima F, Nishio R, Nakayama B, Igawa O, Shigemasa C, Hisatome I. Autoperipheral blood mononuclear cell transplantation improved giant ulcers due to chronic arteriosclerosis obliterans. Heart Vessels 2006;21:258-262
45. +cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial. Stem Cells 2009;27:2857-2864
46. Lee KB, Kim DI. Clinical application of stem cells for therapeutic angiogenesis in patients with peripheral arterial disease. International J of Stem Cells 2009;2:11-17
47. Rowlands TE, Donnelly R. Medical therapy for intermittent claudication. Eur J of Vasc and Endovasc Surg 2007; 34:314-321
48. Risau W. Mechanisms of angiogenesis. Nature 1997;386:671-674
49. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshimoto K, Akashi H, Shimada K, Iwasaka T, Imaizumi T; Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bonemarrow cells: a pilot study and a randomised controlled trial. Lancet 2002;360:427-435
50. Higashi Y, Kimura M, Hara K, Noma K, Jitsuiki D, Nakagawa K, Oshima T, Chayama K, Sueda T, Goto C, Matsubara H, Murohara T, Yoshizumi M. Autologous bone marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia. Circulation 2004;109:1215-1218
51. Huang P, Li S, Han M, Xiao Z, Yang R, Han ZC. Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care 2005;28: 2155-2160
52. Kawamura A, Horie T, Tsuda I, Abe Y, Yamada M, Egawa H, Iida J, Sakata H, Onodera K, Tamaki T, Furui H, Kukita K, Meguro J, Yonekawa M, Tanaka S. Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell (PBSC) transplantation in 92 patients with critically ischemic limbs. J Artif Organs 2006;9:226-233
53. Lenk K, Adams V, Lurz P, Erbs S, Linke A, Gielen S, Schmidt A, Scheinert D, Biamino G, Emmrich F, Schuler G, Hambrecht R. Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia. Eur Heart J 2005; 26:1903-1909
54. Lee KB, Kim AK, Kim MJ, Do YS, Shin SW, Kim JS, Park CJ, Kang KS, Kim BS, Joh JH, Oh WI, Hong HK, Kim DI. Angiogenesis induced by autologous whole bone marrow stem cells transplantation. International J of Stem Cells 2008;1:64-69
55. Kim DI, Kim MJ, Joh JH, Shin SW, Do YS, Moon JY, Kim NR, Lim JE, Kim AK, Eo HS, Kim BS, Cho SW, Yang SH, Park CJ, Shim JS. Angiogenesis facilitated by autologous whole bone marrow stem cell transplantation for Buerger's disease. Stem Cells 2006;24:1194-1200
56. Arai M, Misao Y, Nagai H, Kawasaki M, Nagashima K, Suzuki K, Tsuchiya K, Otsuka S, Uno Y, Takemura G, Nishigaki K, Minatoguchi S, Fujiwara H. Granulocyte colony-stimulating factor: a noninvasive regeneration therapy for treating atherosclerotic peripheral artery disease. Circ J 2006;70:1093-1098
57. Durdu S, Akar AR, Arat M, Sancak T, Eren NT, Ozyurda U. Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans. J Vasc Surg 2006;44:732-739
58. Huang PP, Yang XF, Li SZ, Wen JC, Zhang Y, Han ZC. Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans. Thromb Haemost 2007;98:1335-1342
59. Matoba S, Tatsumi T, Murohara T, Imaizumi T, Katsuda Y, Ito M, Saito Y, Uemura S, Suzuki H, Fukumoto S, Yamamoto Y, Onodera R, Teramukai S, Fukushima M, Matsubara H; TACT Follow-up Study Investigators. Longterm clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia. Am Heart J 2008;156:1010-1018
60. Miyamoto K, Nishigami K, Nagaya N, Akutsu K, Chiku M, Kamei M, Soma T, Miyata S, Higashi M, Tanaka R, Nakatani T, Nonogi H, Takeshita S. Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans. Circulation 2006;114:2679-2684
61. Motukuru V, Suresh KR, Vivekanand V, Raj S, Girija KR. Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells. J Vasc Surg 2008;48(6 Suppl):S53-60
62. Saito Y, Sasaki K, Katsuda Y, Murohara T, Takeshita Y, Okazaki T, Arima K, Katsuki Y, Shintani S, Shimada T, Akashi H, Ikeda H, Imaizumi T. Effect of autologous bonemarrow cell transplantation on ischemic ulcer in patients with Buerger's disease. Circ J 2007;71:1187-1192